Hilleman Jeryl L
SEC-identified person · CIK 1216628 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Omada Health, Inc. OMDA | Director | filed 2025–2026 |
| SI-Bone, Inc. SIBN | Director | filed 2019–2026 |
| Novocure Ltd NVCR | Director | filed 2018–2026 |
| Hillevax, Inc. HLVX | Director | filed 2022–2025 |
| Cutera INC CUTR | Director | filed 2024–2024 |
| Minerva Neurosciences, Inc. NERV | Director | filed 2018–2023 |
| Talis Biomedical Corp TLIS | Director | filed 2021–2021 |
| Intersect ENT, Inc. XENT | Chief Financial Officer | filed 2014–2019 |
| Xenoport INC XNPT | Director | filed 2006–2016 |
| Tranzyme INC TZYM | Chief Financial Officer | filed 2013–2013 |
| Amyris, INC. AMRS | Chief Financial Officer | filed 2010–2011 |
| Symyx Technologies INC SMMX | Exec. Vice President and CFO | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.